Featured Articles

  1. A New Prescription For R&D Tax Credit Reporting 6/20/2025

    New IRS requirements for R&D tax credits are coming into effect for tax year 2025. Life sciences companies should prepare for the changes now, explains Sophia Shah, a CPA at Crowe.

  2. Structuring Cross Border China Biotech 'NewCo' Transactions 6/18/2025

    Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets to form a U.S.-based 'Newco,' explain experts at Orrick.

  3. Using Generative AI For Smarter, Faster, More Predictive Biopharma Ops 6/16/2025

    Experts at PA Consulting offer case studies and advice for using generative AI to improve biopharma manufacturing, mitigate risk, and comply with emerging AI regulations.

  4. EU Launches Strategic Bid To Attract R&D And Investments In Biotech 6/12/2025

    The European Union (EU) is actively courting biotech for economic growth and has launched several initiatives to attract investment and speed innovation to market, explain experts at Sidley.

  5. Winning With The Right Marbles: The Future of Generics 6/11/2025

    After decades of racing to the bottom on pricing, a revolution is coming to the U.S. generics market, writes Yaral Pharma CEO Stephen Beckman.

  6. The Shift From LAL To Recombinant: What Your Lab Should Expect 6/10/2025

    Advocacy for alternatives to animal testing in clinical research is pushing the industry away from animal-based endotoxin testing. Charles River Labs' Nicola Reid lays out the issues to consider.

  7. U.S. Tariffs And Their Tenuous Impact On Clinical Trials 6/10/2025

    RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.

  8. Bracing For The Impact Of The Federal Workforce Reduction 6/9/2025

    The federal workforce reductions pose significant challenges for the life sciences industry, particularly for R&D, supply chain oversight, and industry workforce development.

  9. Life Sciences Business Strategies For Trump 2.0 Policy Changes 6/6/2025

    Experts at Faegre Drinker offer life sciences business planning and risk mitigation strategies to consider in response to enacted or anticipated policy changes under the Trump administration.

  10. Winning Management Strategies For Early And Late-Stage Drug Development 6/4/2025

    Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early and late-stage drug development, explains Halloran's Carolina Ahrendt.